Bactericidal activity of biosynthesized silver nanoparticles against human pathogenic bacteria by Abalkhil, T.A. et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=tbeq20
Download by: [University of Sheffield] Date: 26 June 2017, At: 03:57
Biotechnology & Biotechnological Equipment
ISSN: 1310-2818 (Print) 1314-3530 (Online) Journal homepage: http://www.tandfonline.com/loi/tbeq20
Bactericidal activity of biosynthesized silver
nanoparticles against human pathogenic bacteria
Tarad Abdulaziz Abalkhil, Sulaiman Ali Alharbi, Saleh Hussein Salmen &
Milton Wainwright
To cite this article: Tarad Abdulaziz Abalkhil, Sulaiman Ali Alharbi, Saleh Hussein Salmen &
Milton Wainwright (2017) Bactericidal activity of biosynthesized silver nanoparticles against
human pathogenic bacteria, Biotechnology & Biotechnological Equipment, 31:2, 411-417, DOI:
10.1080/13102818.2016.1267594
To link to this article:  http://dx.doi.org/10.1080/13102818.2016.1267594
© 2016 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group
Published online: 20 Dec 2016.
Submit your article to this journal 
Article views: 302
View related articles 
View Crossmark data
ARTICLE; PHARMACEUTICAL BIOTECHNOLOGY
Bactericidal activity of biosynthesized silver nanoparticles against
human pathogenic bacteria
Tarad Abdulaziz Abalkhila, Sulaiman Ali Alharbia, Saleh Hussein Salmena and Milton Wainwrightb
aDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia; bDepartment of Molecular
Biology and Biotechnology, University of Shefﬁeld, Shefﬁeld, UK
ARTICLE HISTORY
Received 27 March 2016
Accepted 29 November 2016
ABSTRACT
Green synthesis is an attractive and eco-friendly approach to generate potent antibacterial silver
nanoparticles (Ag-NPs). Such particles have long been used to ﬁght bacteria and represent a
promising tool to overcome the emergence of antibiotic-resistant bacteria. In this study, green
synthesis of Ag-NPs was attempted using plant extracts of Aloe vera, Portulaca oleracea and
Cynodon dactylon. The identity and size of Ag-NPs was characterized by ultraviolet–visible
spectrophotometer and scanning electron microscopy. Monodispersed Ag-NPs were produced
with a range of different sizes based on the plant extract used. The bactericidal activity of Ag-NPs
against a number of human pathogenic bacteria was determined using the disc diffusion method.
The results showed that Gram positive bacteria were more susceptible than Gram negative ones to
these antibacterial agents. The minimum inhibitory concentration was determined using the 96-
well plate method. Finally, the mechanism by which Ag-NPs affect bacteria was investigated by
SEM analysis. Bacteria treated with Ag-NPs were seen to undergo shrinkage and to lose their
viability. This study provides evidence for a cheap and effective method for synthesizing potent
bactericidal Ag-NPs and demonstrates their effectiveness against human pathogenic bacteria.
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Introduction
The emergence of antibiotic resistant bacteria is strongly
linked to an increase in the use of antibiotics over the
last 70 or so years. Such antibiotic resistant bacteria rep-
resent a continuous threat to humans, especially since
more than 60% of bacteria causing nosocomial infec-
tions are resistant to at least one of the antibiotics most
commonly used in their treatment [1]. Individuals
infected with multidrug resistant (MDR) bacteria are not
easily treated and as a result, remain hospitalized for
long periods [2]. As a result, attempts to ﬁnd alternative
approaches to antibiotics in order to avoid the further
development of antibiotic resistance are an essential
research aim. Silver, and its derivatives, have long been
used as antimicrobial agents against bacteria, fungi and
viruses [3–5]. The nano-form of silver has emerged as an
alternative approach to antibiotics which need to be fur-
ther evaluated to determine their effectiveness and
safety in vivo. Silver nanoparticles (Ag-NPs) can be syn-
thesized by several chemical, physical and biological
methods [6–9]. However, biological methods prove to
be particularly cost-effective, nontoxic and eco-friendly
methods for generating Ag-NPs [10,11]. Numerous
ecofriendly biological sources can be used for biosynthe-
sis of Ag-NPs which have potent antimicrobial activities
[12–15]. Lately, Ag-NPs have been synthesized by various
extracts of plants such as leaves of Rosmarinus ofﬁcinalis
[16], cowpea seeds (Vigna sp. L) [17], root extracts of Dio-
spyros paniculata [18] and Terminaliachebula leaf extract
[19] in addition to microorganisms such as Aspergillus
terreus [20] and some products like monosaccharides
[21]. Plant extracts are particularly effective due to their
rich contents of bio-reducing agents which include: ter-
penoids, ﬂavones, ketones, aldehydes, amides, carbox-
ylic acids, proteins, DNA and enzymes – all of which
mediate the reduction process and Ag-NPs precipitation
[22]. The bactericidal activities of Ag-NPs against a wide
array of MDR pathogenic bacteria, including Gram posi-
tive and Gram negative species, have been investigated
in several studies which have shown that Ag-NPs are
effective against Pseudomonas aeruginosa, ampicillin-
resistant Escherichia coli, erythromycin-resistant Strepo-
coccus pyogenes, methicillin-resistant Staphylococcus
aureus (MRSA) and vancomycin-resistant Staphylococcus
aureus (VRSA) [23–28]. Ag-NPs are particularly useful
because they can be effectively incorporated into
CONTACT Tarad Abdulaziz Abalkhil tradabdulaziz@yahoo.com; Saleh Hussein Salmen ssalmen@ksu.edu.sa
© 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2017
VOL. 31, NO. 2, 411–417
http://dx.doi.org/10.1080/13102818.2016.1267594
dressings used to treat wounds and burns [29–32]. In the
present study, the biosynthesis of Ag-NPs was achieved
by the reduction of silver nitrate using plant extracts as
bio-reducing agents. Three plants were selected for the
reduction process on the basis of their availability and
ease of extraction. Synthesized Ag-NPs were analysed by
ultraviolet (UV)–visible spectrophotometer and scanning
electron microscopy (SEM). In addition, the bactericidal
activity of Ag-NPs was tested against nine human patho-
genic bacteria for determination of the minimum inhibi-
tory concentration (MIC).
Materials and methods
Materials
Plants, chemicals and media: Three plants, Aloe vera,
Portulaca oleracea and Cynodon dactylon; silver nitrate
(Sigma–Aldrich, Munich, Germany), Muller-Hinton agar
(MHA) (Sigma–Aldrich) and Nutrient broth (Sigma–
Aldrich) were used. Bacterial strains: nine human patho-
genic bacteria (obtained from the Botany and Microbiol-
ogy Department, College of Science, King Saud
University) were used, namely the Gram positive bacte-
ria: Bacillus subtilis, Bacillus cereus, Staphylococcus aureus
and Enterococcus faecalis, and Gram negative Salmonella
typhi, Shigella sp., Escherichia coli, Pseudomonas aerugi-
nosa and Acinetobacter baumannii.
Biosynthesis and characterization of silver
nanoparticles
Broths from leaves of the three plants were prepared (A.
vera, P. oleracea and C. dactylon). Fifty grams of leaves
from each plant were rinsed several times with distilled
water and cut into small pieces. The leaves were then
boiled in three Erlenmeyer ﬂasks (one for each plant)
containing 200 mL of sterile, distilled water for
10 minutes. The extracts were allowed to cool and were
then transferred to 50 mL falcon tubes and centrifuged
at 15,000 rpm for 15 minutes (Universal 320R, Hettich,
Germany). Supernatants containing the bio-reducing
agents were then ﬁltered using syringe ﬁlters into new
sterile 50 mL falcon tubes. Plant extract (15 mL) was
next added to an aqueous solution of silver nitrate
(1 mmol/L). Upon mixing, a change in colour indicated
the formation of monodispersed Ag-NPs. A further two
ﬂasks were used as controls where one ﬂask contained
only plant extract with water and the second contained
only a Ag-solution. Biosynthesized Ag-NPs were sepa-
rated from the solution by centrifugation (Universal
320R) at 15,000 rpm for 15 minutes, washed several
times and then kept in the refrigerator for further
studies. The biosynthesis process was performed for
each plant giving three types of Ag-NPs. They were des-
ignated as A, B and C for, respectively, A. vera, P. oleracea
and C. dactylon. The identity of Ag-NPs was characterized
by UV–visible spectrophotometer (PerkinElmer LAMBDA,
Waltham, USA). Spectra of surface plasmon resonance
were obtained at different time intervals. The morphol-
ogy and size of Ag-NPs were determined by SEM.
Bactericidal activities of Ag-nanoparticles
Bacterial strains were passaged three times in nutrient
broth medium to restore their optimal physiological
activities. In vitro bactericidal activity was assayed using
MHA. Bacterial strains were tested against the three
types of biosynthesized Ag-NPs (A, B and C). A range of
concentrations of Ag-NPs (A, B and C) were tested, i.e.
(50 mg/mL, 5 mg/mL and 0.5 mg/mL). Paper discs were
soaked in each concentration. Each of the bacterial strain
cell susupensions (100 mL) was inoculated onto the
medium and spread (using a glass rod) across the
medium and allowed to dry for 5 min. Ag-NPs-loaded
discs were then placed on the surface of the medium
and the compound was allowed to diffuse for 5 minutes.
The plates were then incubated at 37 C for 24 h. At the
end of incubation, any inhibition zones which formed
around the disc were measured. Disks soaked in steril-
ized water were used as controls. The diameter of any
control zones was subtracted from the test zones and
the resulting zone diameter and the result obtained was
tabulated. Finally, discs loaded with streptomycin (15 mg
/disc) were used as positive control. The experiment was
performed throughout in triplicate.
Determination of the MIC
The MIC was determined using the 96-well plate method;
three 96-well plates being used, one for each Ag-NPs (A,
B and C). The ﬁrst nine columns were assigned for each
bacterial strain and were inoculated with 125 mL of bacte-
rial culture. Then, 125 mL of pre-weighted Ag-NPs of each
type were inoculated in the ﬁrst row (A) and then a two-
fold serial dilution was performed. Only the row H was
left as negative control (without Ag-NPs). The last three
columns, 10, 11 and 12, were left as blank. The plates
were incubated at 37 C for 24 h. Plates were read by
Microplate reader (Mithras LB 940, Berthold Technologies,
Bad Wildbad, Germany) at 690 nm wavelength and MICs
were recorded as the lowest concentration of Ag-nano-
particles showing no visible growth in the broth. Samples
from wells used in broth microdilution assay that did not
exhibit any visible growth after the 24 h incubation were
subcultured onto MHA plates.
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Scanning electron microscopy
SEM analysis was used to analyse the bactericidal
mechanism of these nanoparticles. Ag-NPs was inocu-
lated into a growing culture of S. aureus and incu-
bated overnight. Non-treated culture was used as
control. Samples from both cultures were then proc-
essed and examined by SEM (JSM-6380 LA, Tokyo,
Japan).
Results and discussion
Green synthesis and characterization of Ag-NPs
Ag-NPs were formed immediately by mixing silver
nitrate solution and leaf-broth as indicated by an
observed colour change, with solution colour becom-
ing completely dark after 2 h. The identity of Ag-NPs was
conﬁrmed from absorption spectra recorded by UV–
visible spectrophotometer (Figure 1). The various types
of Ag-NPs, A. vera (A), P. oleracea (B) and C. dactylon (C),
had different peak values of 405, 415 and 420 nm,
respectively. Stable and monodispersed Ag-NPs were
recovered and monitored by SEM (Figure 2). The resul-
tant SEM images showed that the nanoparticles
were spherical shaped and from 10 to 30 nm for type A,
15–40 nm for type B and 25–60 nm for type C.
Ag-NPs have recently received much attention due to
their bactericidal activities against a broad spectrum of
pathogenic bacteria. A number of physical, chemical and
biological methods have been described in order to syn-
thesize nanoparticles of silver. Of these, biological, or
green, synthesis is the most environmentally benign and
cost effective approach [33–36]. Numerous biological
materials from different sources can be used to synthe-
size Ag-NPs, and bacterial, fungal and plant extracts
have been employed for Ag-NPs biosynthesis [37,38].
Several papers report the use of different plant extracts
Figure 1. UV–visible spectrum for the reaction of plant extracts
with AgNO3 solution.
Figure 2. SEM images showing well-dispersed silver nanoparticles formed by extracts of plants: A. vera (A), P. oleracea (B) and C. dacty-
lon (C).
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such as Emblica ofﬁcinalis [35], Parthenium [39], Aloe vera
[40], Pisonia grandis [41], Jatropha curcas [8] and Justicia
genderussa [42].
In this study, extracts from three plants, A. vera, P. oler-
acea and C. dactylon were used to reduce silver ions into
Ag-NPs (Figure 1). The morphology and resonance prop-
erties of Ag-NPs were examined by SEM and UV–visible
spectrophotometer, respectively. The size, distribution
and stability of Ag-NPs were seen to vary with the plant
extract, or the organism used for the biosynthesis pro-
cess. Surface plasmon resonance of Ag-NPs reported in
previous studies displayed different peak values: E. coli
(400 nm) [43], Aspergillus niger (420 nm) [44], Pisonia
grandis (420 nm) [41], Merrimia tridendata (440 nm) [45],
Kappaphycus alvarezii (420 nm) [46], Citrullus colocynthis
(440 nm) [47] and Allium cepa (412 nm) [48]. The Ag-NPs
obtained in this study were uniform spherical and varied
according to the plant extract. Other investigators have
synthesized different sizes of Ag-NPs: 30–40 nm, for
example, by Boswellia ovalifoliolata [49]; 30–50 nm by
Merremia tridendata [45], Carcia papaya [50] and Emblica
ofﬁcinalis [35].
Antimicrobial activities of Ag-NPs
In order to evaluate the bactericidal activities of Ag-NPs,
the disc diffusion method was used here. The inhibition
zones around Ag-NPs-loaded disks were measured and
recorded. Biosynthesized Ag-NPs (A, B and C) were found
to have potent bactericidal activities against both Gram
positive and Gram negative bacteria. However, the bac-
tericidal potential was more effective against Gram posi-
tive bacteria than against Gram negative ones (Table 1).
Ag-NPs type A formed by the extract from A. vera was
more effective than extracts B and C. For the three types
of Ag-NPs, the highest effect was observed at a concen-
tration of 50 mg/mL. The diameter of the inhibition zone
was smaller at a concentration of 5 mg/mL and consider-
ably smaller at 0.5 mg/mL.
Ag-NPs exhibited antibacterial activity against B. subti-
lis, B. cereus, S. aureus, Enterococcus faecalis, S. typhi,
Shigella sp., E. coli, P. aeruginosa and A. baumannii. Similar
antibacterial activity of Ag-NPs has been reported against
E. coli and P. aeruginosa; B. cereus and P. aeruginosa [51];
P. aeruginosa, E. coli, Streptococcus pyrogens and Samo-
nella enteritis [48]; Proteus vulgaris, Vibrio [52]; S. aureus, B.
subtilis, E. coli and Klebsiella pneumoniae [53]; Samonella
typhi and E. coli [54]; Proteus morgani and S. aureus [55].
MIC
Table 2 shows the MIC values of different Ag-NPs as
measured by Microplate reader at 690 nm wavelength.
Higher concentrations of Ag-nanoparticles (A, B and C)
were found to completely inhibit bacterial growth. The
effect gradually decreased with decreasing concentra-
tions. The average MIC value of Ag-NPs from A. vera
against Gram positive bacteria was 2.1 mg/L and
3.2 mg/L against Gram negative bacteria. The average
MIC values for Ag-NPs of P. oleracea were 3 mg/L for
Gram-positive bacteria and 4.27 mg/L for Gram negative
ones. Finally, for Ag-NPs of C. dactylon, the average MIC
values were 4.57 mg/L and 5.82 mg/L for Gram positive
and Gram negative bacteria, respectively.
Although the bactericidal activities of Ag-NPs were
seen in this study to vary among bacterial species, the
effect was greater against Gram positive than against
Gram negative bacteria (Table 2). This is due to the fact
that the cell walls of Gram positive bacteria bind larger
quantities of metals than do Gram negative bacteria
Table 1. Antibacterial activities of Ag-NPs biosynthesized by extracts from A. vera (A), P. oleracea (B) and C. dactylon (C).
Zone of inhibition (mm diameter)
50 mg/mL 5 mg/mL 0.5 mg/mL
Bacterial strain A B C A B C A B C Streptomycin Negative control
B. subtilis 16.5 15.0 15.6 14.8 12.8 14.2 10.8 8.8 10.0 28.7 0.0
B. cereus 11.4 9.4 12.7 8.1 7.1 8.7 5.4 4.8 5.7 25.9 0.0
S. aureus 18.1 17.7 16.5 16.3 14.8 13.3 13.4 12.8 13.0 31.0 0.0
E. faecalis 6.2 5.2 5.9 4.2 3.2 4.2 2.5 2.9 2.8 27.7 0.0
S. typhi 6.3 5.5 6.0 4.2 4.0 5.1 3.4 3.2 3.2 24.8 0.0
Shigella sp. 5.4 5.8 7.0 4.6 4.0 5.0 2.8 2.2 3.8 21.3 0.0
E. coli 6.0 4.9 5.0 3.8 3.2 4.5 3.4 2.8 3.0 40.7 0.0
P. aeruginosa 6.4 5.0 6.0 6.0 4.8 5.6 3.3 3.0 3.0 16.9 0.0
A. baumannii 5.8 4.8 5.0 4.7 4.2 4.7 3.8 3.0 2.8 18.9 0.0
Table 2. MIC values of different types of Ag-NPs biosynthesized
by extracts from A. vera (A), P. oleracea (B) and C. dactylon (C).
MIC (mg(Ag)/L)
Bacterial strain A (10–30 nm) B (15–40 nm) C (25–60 nm)
B. subtilis 2.6 3.2 4.8
B. cereus 2.4 3.25 4.5
S. aureus 1.5 2.8 5
E. faecalis 2 3 4
S. typhi 3 4 6
Shigella sp. 2.9 4.2 6.5
E. coli 3.4 4.35 5.5
P. aeruginosa 3 3.8 5.7
A. baumannii 3.7 5 5.4
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[56]. Another factor that plays a major bactericidal role is
the size of Ag-NPs, where small size Ag-NPs are more
effective than larger ones (Table 2). To investigate the
relation between the size of Ag-NPs and their bacteri-
cidal activities, the MIC values for each type (A, B and C)
were measured using the micro-dilution method. Small
Ag-NPs (type A) showed more pronounced bactericidal
activities than types B and C. These results are similar to
those reported by other investigators [57–59].
Mechanism of Ag-NPs action
The mechanism of Ag-NPs action was also investigated
in the present study. Ag-NPs-treated S. aureus brought
about cell-shrinkage, indicating permeability and a loss
of viability (Figure 3). These ﬁndings support the obser-
vation that Ag-NPs adhere to, and then form pits on bac-
terial cell walls. The exact mechanisms by which Ag-NPs
exert their bactericidal action are not known, although a
number of theories have been suggested. Gogoi et al.
[60], for example, proposed that Ag-NPs have no direct
effect on cellular DNA and proteins [60]; adherence of
Ag-NPs to bacterial cell wall results in the formation of
pits which, in turn, lead to permeability loss and cell
death [59]. Free radicals generation and the release of sil-
ver ions by Ag-NPs are also possible mechanisms that
may lead to cell death [61,62].
Conclusions
Green synthesis of Ag-NPs was attempted using extracts
from A. vera, P. oleracea and C. dactylon. Characterization
of Ag-NPs by SEM and UV–visible spectrophotometer
revealed spherical nanoparticles exhibiting a range of
different sizes. Biosynthesized Ag-NPs exhibited bacteri-
cidal activities against both Gram positive and Gram
negative bacteria used in this study. The relation
between Ag-NPs size and bactericidal activity was eluci-
dated by measuring MIC values of different Ag-NPs.
Small-sized Ag-NPs synthesized by A. vera were more
Figure 3. SEM analysis of non-treated control bacterial cells (A) and S. aureus treated with Ag-NPs formed by extracts from A. vera (B), P.
oleracea (C) and C. dactylon (D).
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effective than those synthesized by P. oleracea and C.
dactylon. We also investigated the mechanism of Ag-NPs
and observed that treated bacteria undergo cell-shrink-
age, thereby indicating loss of permeability and viability.
Finally, the results of this study suggest an eco-friendly,
cost-effective and rapid method for the generation of
bactericidal Ag-NPs.
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